Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 30, 2026 | $3.30 | +44.1% | $6.59B | +9.4% | $3.49 |
| Q1 FY26ended Mar 31, 2026 | May 7, 2026 | $1.93 | +14.2% | $6.02B | +2.6% | $3.00 |
| Q4 FY25ended Dec 31, 2025 | — | $2.20 | +56.0% | $7.17B | +11.4% | — |
| Q3 FY25ended Sep 30, 2025 | — | $2.22 | +2.8% | $6.06B | +10.2% | — |
| Q2 FY25ended Jun 30, 2025 | — | $2.29 | +7.0% | $6.02B | +11.1% | — |
| Q1 FY25ended Mar 31, 2025 | — | $1.69 | −17.6% | $5.87B | +11.9% | — |
| Q4 FY24ended Dec 31, 2024 | — | $1.41 | −52.7% | $6.44B | +10.7% | — |
| Q3 FY24ended Sep 30, 2024 | — | $2.16 | +20.0% | $5.49B | +11.9% | — |
| Q2 FY24ended Jun 30, 2024 | — | $2.14 | — | $5.42B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $2.05 | — | $5.24B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $2.98 | — | $5.82B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $1.80 | — | $4.91B | — | — |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Stryker shares, not any token. As of Jul 30, 2026, from Massive's standardised financials and the earnings calendar.